- Home
- CYH vs PRQR Comparison
CYH vs PRQR Comparison
Compare CYH & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYH
- PRQR
- Stock Information
- Founded
- CYH 1985
- PRQR 2012
- Country
- CYH United States
- PRQR Netherlands
- Employees
- CYH N/A
- PRQR N/A
- Industry
- CYH Hospital/Nursing Management
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- CYH Health Care
- PRQR Health Care
- Exchange
- CYH Nasdaq
- PRQR Nasdaq
- Market Cap
- CYH 362.0M
- PRQR 309.5M
- IPO Year
- CYH 1991
- PRQR 2014
- Fundamental
- Price
- CYH $3.51
- PRQR $1.55
- Analyst Decision
- CYH Hold
- PRQR Strong Buy
- Analyst Count
- CYH 8
- PRQR 6
- Target Price
- CYH $4.02
- PRQR $9.00
- AVG Volume (30 Days)
- CYH 3.4M
- PRQR 678.2K
- Earning Date
- CYH 04-23-2025
- PRQR 05-08-2025
- Dividend Yield
- CYH N/A
- PRQR N/A
- EPS Growth
- CYH N/A
- PRQR N/A
- EPS
- CYH N/A
- PRQR N/A
- Revenue
- CYH $12,653,000,000.00
- PRQR $21,212,711.00
- Revenue This Year
- CYH N/A
- PRQR $6.44
- Revenue Next Year
- CYH $4.15
- PRQR N/A
- P/E Ratio
- CYH N/A
- PRQR N/A
- Revenue Growth
- CYH 1.05
- PRQR 85.91
- 52 Week Low
- CYH $2.24
- PRQR $1.07
- 52 Week High
- CYH $6.29
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- CYH 72.58
- PRQR 52.58
- Support Level
- CYH $2.77
- PRQR $1.47
- Resistance Level
- CYH $3.50
- PRQR $2.02
- Average True Range (ATR)
- CYH 0.20
- PRQR 0.15
- MACD
- CYH 0.10
- PRQR 0.02
- Stochastic Oscillator
- CYH 90.09
- PRQR 41.13
About CYH Community Health Systems Inc.
Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.